Lantheus Holdings to Be Acquired for Initial $6.7 Billion
Dow Jones2026/08/03 11:58By Colin Kellaher
Lantheus Holdings has agreed to be acquired by Curium, a fellow radiopharmaceutical company controlled by investment firm CapVest Partners, for an initial $6.7 billion.
Curium on Monday said it will pay $102.50 a share in cash for Lantheus, a 2.9% premium to Friday's closing price of $99.64 for the Bedford, Mass., company.
The deal, slated to close in the first half of 2027, includes contingent value rights tied to Lantheus' commercial portfolio that are worth up to an additional $12 a share, bringing the total potential value to $114.50 a share, Curium said.
CapVest, which has $20 billion in assets under management, established Curium in 2017 and remains its controlling shareholder after a recapitalization transaction last year that valued Curium at about $7 billion.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
August 03, 2026 07:58 ET (11:58 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Update 2 - Vestas’ profits hit by sluggish sales and wind turbine blade failures
BUZZ – Gold mining stocks rise as gold price rebounds from sell-off
Australian Dollar seen vulnerable after weak data – Societe Generale
Crypto prices
More
